首页> 美国卫生研究院文献>Journal of Thoracic Disease >Bedside troubleshooting during venovenous extracorporeal membrane oxygenation (ECMO)
【2h】

Bedside troubleshooting during venovenous extracorporeal membrane oxygenation (ECMO)

机译:静脉静脉体外膜氧合(ECMO)期间的床边故障排除

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this review, we discuss common difficulties that clinicians may encounter while managing patients treated with venovenous (VV) extracorporeal membrane oxygenation (ECMO). ECMO is an increasingly important tool for managing severe respiratory failure that is refractory to conventional therapies. Its overall goal is to manage respiratory failure-induced hypoxemia and hypercarbia to allow “lung rest” and promote recovery. Typically, by the time VV-ECMO is initiated, the patient’s pulmonary condition requires conventional ventilator settings that are detrimental to lung recovery or that exceed the remaining functional lung’s ability to maintain acceptable physiological conditions. Standard mechanical ventilation can activate inflammation and worsen the pulmonary damage caused by the underlying disease, leading to ventilator-induced lung injury. In contrast, VV-ECMO facilitates lung-protective ventilation, decreasing further ventilator-induced lung injury and allowing lung recovery. Such lung-protective ventilation seeks to avoid barotrauma (by monitoring transpulmonary pressure), volutrauma (by reducing excessive tidal volume to promote lung rest), atelectotrauma [by maintaining adequate positive end-expiratory pressure (PEEP)], and oxygen toxicity (by decreasing ventilator oxygen levels when PEEP is adequate). ECMO for adult respiratory failure was associated with overall survival of 62% in 2018, according to the Extracorporeal Life Support Organization (ELSO) January 2019 registry report. Difficulties that may arise during VV-ECMO require timely diagnosis and optimal management to achieve the most favorable outcomes. These difficulties include ventilation issues, hypoxemia (especially as related to recirculation or low ECMO-flow-to-cardiac-output ratio), sepsis, malfunctioning critical circuit components, lack of clarity regarding optimal hemoglobin levels, hematological/anticoagulation complications, and right ventricular (RV) dysfunction. A culture of safety should be emphasized to optimize patient outcomes. A properly functioning team—not only the bedside clinician, but also nurses, perfusionists, respiratory therapists, physical therapists, pharmacists, nutritionists, and other medical specialists and allied health personnel—is vital for therapeutic success.
机译:在这篇综述中,我们讨论了临床医生在处理经静脉静脉(VV)体外膜氧合(ECMO)治疗的患者时可能遇到的常见困难。 ECMO是处理严重呼吸衰竭的一种日益重要的工具,这种呼吸衰竭是传统疗法所无法承受的。它的总体目标是管理呼吸衰竭引起的低氧血症和高碳血症,以使“肺部休息”并促进康复。通常,在开始VV-ECMO时,患者的肺部状况需要常规的呼吸机设置,这不利于肺部恢复或超出了其余功能性肺部维持可接受的生理状况的能力。标准的机械通气可以激活炎症并加重由潜在疾病引起的肺部损伤,从而导致呼吸机诱发的肺损伤。相反,VV-ECMO促进了肺保护通气,减少了进一步的呼吸机诱发的肺损伤,并使肺恢复。这种肺保护性通气试图避免气压伤(通过监测跨肺压),容积伤(通过减少过多的潮气量以促进肺部休息),肺外伤(通过维持适当的呼气末正压(PEEP))和氧气中毒(通过降低PEEP足够时呼吸机的氧气水平)。根据体外生命支持组织(ELSO)2019年1月的注册表报告,2018年成人呼吸衰竭的ECMO与62%的总生存率相关。 VV-ECMO期间可能出现的困难需要及时诊断和最佳管理,以实现最有利的结果。这些困难包括通气问题,低氧血症(尤其是与再循环或ECMO流量与心脏输出比低有关),败血症,关键回路组件出现故障,关于最佳血红蛋白水平缺乏明确性,血液学/抗凝并发症以及右室(RV)功能障碍。应强调安全文化,以优化患者预后。一个运作良好的团队-不仅是床边临床医生,而且还有护士,灌注师,呼吸治疗师,物理治疗师,药剂师,营养师以及其他医学专家和相关的卫生人员-对于治疗成功至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号